Safety and Efficacy of Sofosbuvir-based Regimens in Clinical Practice for the Treatment of Chronic Hepatitis C Virus Infection in India

Inclusion Criteria: * HCV-infected patients living in India * Treatment with a SOF-based regimen as determined by the patient's treating physician per the approved prescribing information. * Patients who provide written and signed informed consent prior to initiation of treatment where required. Exclusion Criteria: * Concurrent participation in an HCV clinical trial (except trials not testing investigational medicinal products) * Patients presenting a risk of not being able to be followed (eg, patients planning to move or leave the country in a foreseeable future)